Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore groundbreaking advances in colorectal cancer screening through this 46-minute conference talk from Google Cloud's HCLS Summer Camp. Discover how blood-based testing technologies are revolutionizing CRC detection and addressing the critical screening gap affecting nearly 60 million Americans. Learn about the current state of colorectal cancer care in the United States, where CRC remains the second leading cause of cancer deaths despite having a 90% survival rate when detected early. Gain insights from Freenome's Co-Founder and Chief Product Officer, Riley Ennis, as he presents the company's innovative approach to early cancer detection and discusses how emerging blood-based screening methods could transform patient outcomes. Understand the challenges and opportunities in closing the screening gap that leaves 41% of eligible Americans without up-to-date CRC screening, and examine the potential impact of next-generation diagnostic technologies on public health outcomes.
